Published in

Springer Nature [academic journals on nature.com], Leukemia, 1(37), p. 91-101, 2022

DOI: 10.1038/s41375-022-01742-7

American Society of Hematology, Blood, Supplement 1(140), p. 8996-8998, 2022

DOI: 10.1182/blood-2022-159125

Links

Tools

Export citation

Search in Google Scholar

Gilteritinib Activity in Refractory or Relapsed FLT3-Mutated Acute Myeloid Leukemia Patients Previously Treated By Intensive Chemotherapy and Midostaurin: A Study from the French AML Intergroup ALFA/Filo

Journal article published in 2022 by Pierre-Yves Dumas ORCID, Emmanuel Raffoux, Emilie Berard, Emilie Bérard, Sarah Bertoli ORCID, Marie-Anne Hospital, Mael Heiblig ORCID, Yohan Desbrosses, Caroline Bonmati, Cecile Pautas, Juliette Lambert ORCID, Corentin Orvain ORCID, Anne Banos, Florence Pasquier, Pierre Peterlin and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO